HepatologyNews.net

Hepatology Xagena

Search results for "Fibrosis"

The FDA ( Food and Drug Administration ) approved Baraclude ( Entecavir ) tablets and oral solution for the treatment of chronic hepatitis B in adults. Baraclude is indicated for the treatment of ...


Patients with obstructive sleep apnea ( OSA ) are at risk for the development of fatty liver as a result of being overweight. Several data suggest that OSA per se could be a risk factor of liver inj ...


Two studies on hepatitis C ( HCV ) patients who underwent liver transplants examined a potential biomarker that could be used to predict who might develop hepatic fibrosis, a formation of scar-like ti ...


A study, published in the journal Gastroenterology, found that people at high risk for liver injury may be able to reduce their risk for developing chronic liver disease significantly by drinking more ...


A study on patients with cystic fibrosis who have had abnormal bleeding from ruptured blood vessels in the esophagus ( variceal hemorrhage ) as a result of liver disease found that transplant may not ...


A study on the long-term outcome of children undergoing liver transplants found that chronic hepatitis was common and that it was not detectible using standard blood tests. The presence of autoantibo ...


Obese patients chronically infected with the hepatitis C virus ( HCV ) and treated with combination drug therapy may have better outcomes if the underlying abnormalities caused by excessive fat tissue ...


Hepatic fibrosis, the common response associated with chronic liver diseases, ultimately leads to cirrhosis. Researchers showed that activation of hepatic cannabinoid CB2 receptors limits progression ...


Measuring liver stiffness using transient elastography can predict severe portal hypertension in patients with hepatitis C-related cirrhosis.As liver disease progresses, fibrosis leads to portal hyper ...


Patients with chronic hepatitis C and advanced liver disease who drink three or more cups of coffee per day have a 53% lower risk of liver disease progression than non-coffee drinkers.The study found ...


Statins appear to be safe for people with fatty liver disease who could benefit from their cholesterol-lowering capabilities, concludes a review paper.Statins are a class of drugs that lower cholester ...


Low-dose oral Interferon could exert immune-modulating effects in human. Researchers have conducted a clinical trial to investigate the efficacy of oral Interferon-alpha in preventing hepatitis C rela ...


Results from RESTORE , a phase III, multicentre, single-arm, open-label study presented at the International Liver Congress 2014 showed that Simeprevir ( Olysio )150 mg once-daily for 12 weeks in comb ...


The first detailed results from pivotal phase III study, PEARL-III, were presented as part of the 21st Conference on Retroviruses and Opportunistic Infections ( CROI ). PEARL-III evaluated the effica ...


Whether long-term suppression of replication of hepatitis B virus ( HBV ) has any beneficial effect on regression of advanced liver fibrosis associated with chronic HBV infection remains unclear. A s ...